FilingSEC EDGAR424B3
Veraxa Biotech Files Prospectus Supplement Regarding Lincoln Park Capital Agreement
· SEC accepted
StageSupplement
Filing content
The company filed a prospectus supplement to update information regarding its share purchase agreement with Lincoln Park Capital using details from its September 4, 2026, Form 6-K.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…